A Study to Reveal the Patient Characteristics and Treatment Patterns of Stage III Non-small-cell Lung Cancer Patients

This large multinational, non-interventional study (NIS), will retrospectively collect data derived from established medical records over a period of up to approximately 6 years (2013 to 2018), buildi...

Lead sponsor: AstraZeneca•32 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Related studies

RECRUITINGPhase 2/3

Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive Non-Small-Cell Lung Cancer

NCT02448992 · Non-Small-Cell Lung Cancer (NSCLC), Brain Metastasis

COMPLETEDNA

A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung Cancer

NCT01874678 · Non-small-cell Lung Cancer (NSCLC)

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 5, 2020Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment3,111

Start dateNov 2018

Last updatedOct 5, 2020

Condition

Non-small-cell Lung Cancer (NSCLC)

Locations shown

Research Site

Buenos Aires

Research Site

Rosario

Research Site

Santiago

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 5, 2020Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Study to Reveal the Patient Characteristics and Treatment Patterns of Stage III Non-small-cell Lung Cancer Patients

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive Non-Small-Cell Lung Cancer

A Study of TS-1 Plus Cisplatin in Patients With Advanced Non-small-cell Lung Cancer

Trial snapshot

Condition

Locations shown

For caregivers